Yan Tao, Zhuang Junxue, He Lu
Department of Pharmacy, Tianjin Huanhu Hospital, Tianjin 300350, P.R. China.
Department of Pharmacy, Tianjin Baodi Hospital, Baodi Clinical College of Tianjin Medical University, Tianjin 301800, P.R. China.
Oncol Lett. 2019 Aug;18(2):1409-1414. doi: 10.3892/ol.2019.10434. Epub 2019 Jun 4.
Glioma is a malignant tumor that is frequently treated using chemotherapy. The aim of the present study was to examine the antitumor activity of two novel carboxamide derivatives in glioma, and investigate the underlying mechanisms. Two previously designed and synthesized carboxamide derivatives were selected and their effects on glioma cells were evaluated. Specifically, assays to evaluate proliferation, apoptosis, oxidation, caspase-3, -8 and -9 activity, and the expression of Bcl-2 and surviving in glioma cells were conducted. The carboxamide derivatives were revealed to inhibit proliferation, as well as to induce apoptosis and oxidative damage in glioma U251 cells. In addition, the carboxamide derivatives increased the activity of caspase-3, -8 and -9, and suppressed the expression of Bcl-2 and survivin. These findings demonstrate that the carboxamide derivatives displayed antitumor activity against glioma , which may have been mediated via the induction of oxidative damage and apoptosis.
神经胶质瘤是一种常采用化疗进行治疗的恶性肿瘤。本研究的目的是检测两种新型羧酰胺衍生物对神经胶质瘤的抗肿瘤活性,并探究其潜在机制。选择了两种先前设计并合成的羧酰胺衍生物,并评估了它们对神经胶质瘤细胞的作用。具体而言,进行了评估神经胶质瘤细胞增殖、凋亡、氧化、半胱天冬酶-3、-8和-9活性以及Bcl-2和存活蛋白表达的实验。结果显示,羧酰胺衍生物可抑制神经胶质瘤U251细胞的增殖,并诱导其凋亡和氧化损伤。此外,羧酰胺衍生物可增加半胱天冬酶-3、-8和-9的活性,并抑制Bcl-2和存活蛋白的表达。这些发现表明,羧酰胺衍生物对神经胶质瘤具有抗肿瘤活性,其机制可能是通过诱导氧化损伤和凋亡来介导的。